Want to join the conversation?
$MRK said that it is discontinuing the development of odanacatib, its investigational cathepsin K inhibitor for osteoporosis, and will not seek regulatory approval for its use. $MRK has decided to discontinue development after an independent adjudication and analysis of major adverse cardiovascular events confirmed an increased risk of stroke.
Can you imagine a food store with no cash registers? Well, it is coming true soon thanks to $AMZN. The company is opening its new grocery store in Seattle and it has no cash registers. AI takes over!
$AVGO reports 4Q earnings today. I am wondering what to expect.
$SHLD seems to be rolling down the curve, it has been reporting net loss for the past many quarters. The Company Board seems to be doing nothing to stem this trend.